Bayesian Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,901
| Closed | -$372K | – | 703 |
|
|
2024
Q4 | $372K | Buy |
+38,901
| New | +$372K | 0.05% | 440 |
|
|
2021
Q1 | – | Sell |
-5,700
| Closed | -$511K | – | 576 |
|
|
2020
Q4 | $511K | Buy |
5,700
+1,681
| +42% | +$151K | 0.13% | 212 |
|
|
2020
Q3 | $415K | Buy |
+4,019
| New | +$415K | 0.1% | 270 |
|
|
2019
Q2 | – | Sell |
-4,012
| Closed | -$203K | – | 549 |
|
|
2019
Q1 | $203K | Buy |
+4,012
| New | +$203K | 0.04% | 470 |
|
|
2018
Q1 | – | Sell |
-10,084
| Closed | -$469K | – | 638 |
|
|
2017
Q4 | $469K | Buy |
+10,084
| New | +$469K | 0.1% | 331 |
|